Coronary collateral size, flow capacity, and growth: Estimates from the angiogram in patients with obstructive coronary diseaseROCKSTROH, Julia; BROWN, B. Greg.Circulation (New York, N.Y.). 2002, Vol 105, Num 2, pp 168-173, issn 0009-7322Article

Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?BROWN, B. Greg; ZHAO, Xue-Qiao.Journal of the American College of Cardiology. 2007, Vol 49, Num 9, pp 933-938, issn 0735-1097, 6 p.Article

Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-I_Milano (ETC-216) Administration : Magnetic Resonance Imaging Study in an Experimental Model of Atherosclerosis. CommentaryIBANEZ, Borja; VILAHUR, Gemma; FUSTER, Valentin et al.Journal of the American College of Cardiology. 2008, Vol 51, Num 11, issn 0735-1097, 1104-1111 [8 p.]Article

Nicotinic Acid, Alone and in Combinations, for Reduction of Cardiovascular RiskBROWN, B. Greg; ZHAO, Xue-Qiao.The American journal of cardiology. 2008, Vol 101, Num 8A, issn 0002-9149, 58B-62B, SUPArticle

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type lla or Type lib HyperlipidemiaGUYTON, John R; BROWN, B. Greg; FAZIO, Sergio et al.Journal of the American College of Cardiology. 2008, Vol 51, Num 16, pp 1564-1572, issn 0735-1097, 9 p.Article

Tracking atherosclerosis regression : a clinical tool in preventive cardiologyTAYLOR, Allen; SHAW, Leslee J; FAYAD, Zahi et al.Atherosclerosis. 2005, Vol 180, Num 1, pp 1-10, issn 0021-9150, 10 p.Article

Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatmentZAMBON, Alberto; DEEB, Samir S; BROWN, B. Greg et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 6, pp 792-798, issn 0009-7322Article

Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)ZHAO, Xue-Qiao; KRASUSKI, Richard A; BAER, Jefferson et al.The American journal of cardiology. 2009, Vol 104, Num 11, pp 1457-1464, issn 0002-9149, 8 p.Article

Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI : A case-control study. EditorialZHAO, Xue-Qiao; CHUN YUAN; HATSUKAMI, Thomas S et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 10, pp 1563-1564, issn 1079-5642, 9 p.Article

Electron-beam tomography coronary calcium scores are superior to Framingham risk variables for predicting the measured proximal stenosis burdenBROWN, B. Greg; MORSE, Josh; ZHAO, Xue-Qiao et al.The American journal of cardiology. 2001, Vol 88, Num 2A, pp 23E-26E, issn 0002-9149Conference Paper

Safety considerations with niacin therapy. CommentaryGUYTON, John R; BAYS, Harold E; BROWN, B. Greg et al.The American journal of cardiology. 2007, Vol 99, Num 6A, issn 0002-9149, 22C-34C, SUPArticle

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary Atherosclerosis a randomized controlled trialNISSEN, Steven E; TUZCU, E. Murat; GRINES, Cindy L et al.JAMA, the journal of the American Medical Association. 2004, Vol 291, Num 9, pp 1071-1080, issn 0098-7484, 10 p.Article

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary diseaseBROWN, B. Greg; ZHAO, Xue-Qiao; FROHLICH, Jiri et al.The New England journal of medicine. 2001, Vol 345, Num 22, pp 1583-1592, issn 0028-4793Article

Dose-Related Effects of Repeated ETC-216 (Recombinant Apolipoprotein A-I_Milano/ 1-Palmitoyl-2-Oleoyl Phosphatidylcholine Complexes) Administrations on Rabbit Lipid-Rich Soft Plaques : In Vivo Assessment by Intravascular Ultrasound and Magnetic Resonance Imaging. CommentaryPAROLINI, Cinzia; MARCHESI, Marta; BISGAIER, Charles L et al.Journal of the American College of Cardiology. 2008, Vol 51, Num 11, issn 0735-1097, 1098-1103, 1110-1111 [8 p.]Article

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (the HDL Atherosclerosis Treatment Study)ZHAO, Xue-Qiao; MORSE, Josh S; DOWDY, Alice A et al.The American journal of cardiology. 2004, Vol 93, Num 3, pp 307-312, issn 0002-9149, 6 p.Article

Antioxidant vitamins and lipid therapy: End of a long romance?BROWN, B. Greg; CHEUNG, Marian C; LEE, Andrew C et al.Arteriosclerosis, thrombosis, and vascular biology. 2002, Vol 22, Num 10, pp 1535-1546, issn 1079-5642Article

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. EditorialKULLER, Lewis H; CHEUNG, Marian C; ZHAO, Xue-Qiao et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 8, issn 1079-5642, 1253,1320-1326 [8 p.]Article